MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 39 filers reported holding MAST THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $518,000 | +97.0% | 4,190,038 | +38.3% | 0.00% | – |
| Q4 2016 | $263,000 | -68.3% | 3,028,652 | -59.9% | 0.00% | – |
| Q3 2016 | $830,000 | -70.5% | 7,552,722 | +26.0% | 0.00% | – |
| Q2 2016 | $2,818,000 | +102.7% | 5,996,047 | +18.2% | 0.00% | – |
| Q1 2016 | $1,390,000 | -24.0% | 5,072,540 | +16.5% | 0.00% | – |
| Q4 2015 | $1,830,000 | -23.2% | 4,353,424 | +6.0% | 0.00% | – |
| Q3 2015 | $2,382,000 | +19.6% | 4,106,264 | +1.1% | 0.00% | – |
| Q2 2015 | $1,991,000 | +11.1% | 4,062,609 | +9.9% | 0.00% | – |
| Q1 2015 | $1,792,000 | -5.4% | 3,695,062 | +9.2% | 0.00% | – |
| Q4 2014 | $1,894,000 | +20.9% | 3,382,483 | +20.3% | 0.00% | – |
| Q3 2014 | $1,566,000 | -4.9% | 2,810,791 | +7.3% | 0.00% | – |
| Q2 2014 | $1,647,000 | -7.2% | 2,619,137 | +0.3% | 0.00% | – |
| Q1 2014 | $1,775,000 | +116.2% | 2,610,237 | +47.1% | 0.00% | – |
| Q4 2013 | $821,000 | +5.3% | 1,774,744 | -0.1% | 0.00% | – |
| Q3 2013 | $780,000 | +6.8% | 1,776,160 | +4.4% | 0.00% | – |
| Q2 2013 | $730,000 | – | 1,700,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corbenic Partners LLC | 3,000 | $0 | 0.00% |